Qube Research & Technologies LTD Codex Dna, Inc. Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	N/A	400 Added 10000.0%	404 $0
Q4 2023 Feb 13, 2024	SELL	N/A	-6,500 Reduced 99.94%	4 $0
Q3 2023 Nov 13, 2023	BUY	N/A	6,504 New	6,504 $12,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.36 $3,420 - $4,748	2,012 Added 12.74%	17,807 $30,000
Q2 2022 Aug 15, 2022	BUY	$1.8 - $6.45 $28,431 - $101,877	15,795 New	15,795 $28,000
Q3 2021 Nov 12, 2021	SELL	$10.15 - $19.88 $155,670 - $304,899	-15,337 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$17.76 - $22.0 $272,385 - $337,414	15,337 New	15,337 $337,000

307

Ticker DNAY
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 29,518,200
Market Cap $54.6M
Description
Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.